Invesco NASDAQ-100 Equal Weight UCITS ETF Acc

Investment objective: The investment objective of the Fund is to achieve the net total return performance of the NASDAQ-100 Equal Weighted Index (the 'Index'), less fees, expenses and transaction costs. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective, the Fund will, as far as possible and practicable, hold all the shares in the Index in their respective weightings. The Fund may use derivative instruments for the purposes of managing risk, reducing costs, generating additional capital or income. The Fund may engage in securities lending, whereby 90% of the revenues arising from securities lending will be returned to the Fund and 10% of the revenues will be retained by the securities lending agent. The Fund may be exposed to the risk of the borrower defaulting on its obligation to return the securities at the end of the loan period and of being unable to sell the collateral provided to it if the borrower defaults. The Fund's base currency is USD. The Index: The Index is an equal-weighted version of the NASDAQ-100 Index (which measures the performance of 100 of the largest domestic and international Nasdaq-listed non-financial companies by market capitalization). The Index is constructed by including the same constituent securities of the NASDAQ-100 Index but equally weights issuers at each rebalancing date, rather than weighting each issuer by float-adjusted market capitalisation. Security types eligible for inclusion include common stock, ordinary shares, tracking stocks, shares of beneficial interest, limited partnership interests and American Depositary Receipts ('ADRs') including ADRs that represent securities of non-US issuers. The Index is rebalanced on a quarterly basis. This document provides a summary of the principal features of the Index, the complete description of the Index (available from the Index provider) shall at all times prevail. Investors should note that the Index is the intellectual property of th

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No